{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:26:21Z","timestamp":1648657581133},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,6,30]],"date-time":"2007-06-30T00:00:00Z","timestamp":1183161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s00120-007-1464-9","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T06:23:35Z","timestamp":1183011815000},"page":"1135-1137","source":"Crossref","is-referenced-by-count":0,"title":["Schwerpunkt Tumorimmunologie des Transitionalzellkarzinoms"],"prefix":"10.1007","volume":"46","author":[{"given":"P.J.","family":"Olbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,30]]},"reference":[{"key":"1464_CR1","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","volume":"168","author":"Sylvester","year":"2002","unstructured":"Sylvester RJ, Meijden AP van der, Lamm DL (2002) Intravesical bacillus Calmette-Gu\u00e9rin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of clinical trials. J Urol 168: 1964\u20131970","journal-title":"J Urol"},{"key":"1464_CR2","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1097\/01.ju.0000091826.83705.79","volume":"170","author":"De","year":"2003","unstructured":"De Boer EC, Rooijakkers SJ, Schamhart DH, Kurth KH (2003) Cytokine gene expression in a mouse model: the first instillations with viable BCG determine the succeeding Th1-response. J Urol 170: 2004\u20132008","journal-title":"J Urol"},{"key":"1464_CR3","first-page":"955","volume":"72","author":"Tokunaga","year":"1984","unstructured":"Tokunaga T, Yamamoto H, Shimada S et al. (1984) Antitumor activity of deoxyribonucleic acid fraction from mycobacterium bovis BCG. J Natl Cancer Inst 72: 955\u2013962","journal-title":"J Natl Cancer Inst"},{"key":"1464_CR4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nri1396","volume":"4","author":"Ulevitch","year":"2004","unstructured":"Ulevitch RJ (2004) Therapeutics targeting the innate immune system. Nat Rev Immunol 4: 512\u2013520","journal-title":"Nat Rev Immunol"},{"key":"1464_CR5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","volume":"408","author":"Hemmi","year":"2000","unstructured":"Hemmi H, Takeuchi O, Kawai T et al. (2000) A toll like receptor recognizes bacterial DNA. Nature 408: 740\u2013745","journal-title":"Nature"},{"key":"1464_CR6","first-page":"138","volume":"169","author":"Olbert","year":"2003","unstructured":"Olbert P, Hegele A, Dalpke A et al. (2003) Is local immunostimulation of the bladder wall by CpG-ODN possible? First histological evidence in C3H\/He-N mice. J Urol 169: 138","journal-title":"J Urol"},{"key":"1464_CR7","first-page":"146","volume":"27","author":"Olbert","year":"2004","unstructured":"Olbert P, Dalpke A, Schrader AJ et al. (2004) Toll like receptor expression in MB-49 transitional cell carcinoma cells in culture. Onkologie 27: 146","journal-title":"Onkologie"},{"key":"1464_CR8","first-page":"211","volume":"3","author":"Hegele","year":"2004","unstructured":"Hegele A, Dalpke A, Knobloch R von et al. (2004) No direct pro-apoptotic effect of immunostimulative DNA (CpG-ODN) on MB-49 transitional cell carcinoma cells in vitro. Eur Urol Suppl 3: 211","journal-title":"Eur Urol Suppl"},{"key":"1464_CR9","first-page":"2225","volume":"24","author":"Hegele","year":"2004","unstructured":"Hegele A, Dalpke A, Barth P et al. (2004) Antineoplastic effect of immunostimulatory DNA (CpG-ODN) in a murine C57-BL6\/MB-49 transitional cell carcinoma model. Anticancer Res 24: 2225\u20132230","journal-title":"Anticancer Res"},{"key":"1464_CR10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000087380","volume":"26","author":"Hegele","year":"2005","unstructured":"Hegele A, Dalpke A, Heeg K et al. (2005) Immunostimulatory CpG oligonucleotides reduce tumor burden after intravesical administration in an orthotopic murine bladder cancer model. Tumour Biol 26: 274\u2013280","journal-title":"Tumour Biol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-007-1464-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-007-1464-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-007-1464-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T06:58:46Z","timestamp":1558594726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-007-1464-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,30]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["1464"],"URL":"https:\/\/doi.org\/10.1007\/s00120-007-1464-9","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,30]]}}}